4//SEC Filing
Gault Cheryl 4
Accession 0000950170-25-033797
CIK 0002012593other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:00 PM ET
Size
4.9 KB
Accession
0000950170-25-033797
Insider Transaction Report
Form 4
Gault Cheryl
Chief Operating Officer
Transactions
- Award
Common Stock
2025-03-03+13,987→ 171,928 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2024 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in two equal annual installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001839046
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:00 PM ET
- Size
- 4.9 KB